The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies
about
Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birthPrenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birthProgesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practiceVaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface.Maternal characteristics influencing the development of gestational diabetes in obese women receiving 17-alpha-hydroxyprogesterone caproate.Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth.Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial.Efficacy of 17α- hydroxy progestrone on decreasing preterm labor in ART pregnancies: A randomized clinical trial.Use of progestogens in pregnant and infertile patients.Effect of dose and duration of micronized progesterone treatment during the first trimester on incidence of glucose intolerance and on birth weight.Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.Genetic variants in sex hormone pathways and the risk of type 2 diabetes among African-American, Hispanic-American, and European-American postmenopausal women in the United States.
P2860
Q24200953-2C356E13-1C24-4925-BA4A-01643414FCFEQ24244821-AFBEF27A-4CB4-4958-AE91-4F2D4F82E388Q28654984-8A35AE89-1678-476C-B11A-0FB3BAFE5437Q30702434-9A993AC7-991D-4D51-B166-77FF71D2CCB6Q34487386-61015EA7-B1C8-4E6A-81B0-403E3CA038D4Q36357734-880C6797-AC72-495A-BB53-6D478A99EE39Q37101647-9CDA0ACD-0FAC-4E7A-AB22-98A45329BA13Q37615356-818A7E63-129F-42D0-8DD2-6DD7522D1C95Q38006373-CCAD4FC0-6A82-4648-8666-19C1B27A8B83Q43991487-51123198-66EF-489F-BFCE-610B684F7A74Q46301851-6BE2BBBB-D0F2-47FA-95BA-65A33D36C985Q50124738-91C959FC-7E5B-4A56-8DFC-23DF9D9170EB
P2860
The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effect of 17-alpha hydroxy ...... singleton or twin pregnancies
@en
The effect of 17-alpha hydroxy ...... singleton or twin pregnancies.
@nl
type
label
The effect of 17-alpha hydroxy ...... singleton or twin pregnancies
@en
The effect of 17-alpha hydroxy ...... singleton or twin pregnancies.
@nl
prefLabel
The effect of 17-alpha hydroxy ...... singleton or twin pregnancies
@en
The effect of 17-alpha hydroxy ...... singleton or twin pregnancies.
@nl
P2093
P2860
P50
P1476
The effect of 17-alpha hydroxy ...... singleton or twin pregnancies
@en
P2093
Amanda L Horton
Anthony Sciscione
Baha Sibai
Brian M Mercer
Cynthia Gyamfi
Deborah Conway
Jay D Iams
Marshall W Carpenter
Mary Jo O'Sullivan
P2860
P304
P356
10.1016/J.AJOG.2009.06.036
P407
P50
P577
2009-08-29T00:00:00Z